1. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study
- Author
-
Shah, Ravi V., Venkatesh Murthy, Abbasi, Siddique A., Blankstein, Ron, Kwong, Raymond Y., Goldfine, Allison B., Jerosch-Herold, Michael, Lima, Joao A. C., Ding, Jingzhong, and Allison, Matthew A.
- Subjects
Blood Glucose ,Male ,obesity ,Aging ,Clinical Sciences ,Blood Pressure ,Cardiorespiratory Medicine and Haematology ,Intra-Abdominal Fat ,Cardiovascular ,Risk Assessment ,metabolic syndrome ,Article ,Body Mass Index ,Clinical Research ,Predictive Value of Tests ,Risk Factors ,cardiometabolic risk ,Humans ,Obesity ,Tomography ,Metabolic and endocrine ,Nutrition ,Cancer ,Adiposity ,Aged ,Proportional Hazards Models ,Metabolic Syndrome ,screening and diagnosis ,Chi-Square Distribution ,Prevention ,Incidence ,Middle Aged ,Prognosis ,Lipids ,United States ,X-Ray Computed ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,Heart Disease ,Cardiovascular System & Hematology ,Biomedical Imaging ,Tomography, X-Ray Computed ,Biomarkers - Abstract
ObjectivesThis study sought to evaluate differential effects of visceral fat (VF) and subcutaneous fat and their effects on metabolic syndrome (MetS) risk across body mass index (BMI) categories.BackgroundThe regional distribution of adipose tissue is an emerging risk factor for cardiometabolic disease, although serial changes in fat distribution have not been extensively investigated. VF and its alterations over time may be a better marker for risk than BMI in normal weight and overweight or obese individuals.MethodsWe studied 1,511 individuals in the MESA (Multi-Ethnic Study of Atherosclerosis) with adiposity assessment by computed tomography (CT). A total of 253 participants without MetS at initial scan underwent repeat CT (median interval 3.3 years). We used discrete Cox regression with net reclassification to investigate whether baseline and changes in VF area are associated with MetS.ResultsHigher VF was associated with cardiometabolic risk and coronary artery calcification, regardless of BMI. After adjustment, VF was more strongly associated with incident MetS than subcutaneous fat regardless of weight, with a 28% greater MetS hazard per 100 cm(2)/m VF area and significant net reclassification (net reclassification index: 0.44, 95% confidence interval [CI]: 0.29 to 0.60) over clinical risk. In individuals with serial imaging, initial VF (hazard ratio: 1.24 per 100 cm(2)/m, 95% CI: 1.08 to 1.44 per 100 cm(2)/m, p= 0.003) and change in VF (hazard ratio: 1.05 per 5% change, 95% CI: 1.01 to 1.08 per 5% change, p= 0.02) were associated with MetS after adjustment. Changes in subcutaneous fat were not associated with incident MetS after adjustment for clinical risk and VF area.ConclusionsVF is modestly associated with BMI. However, across BMI, a single measure of and longitudinal change in VF predict MetS, even accounting for weight changes. Visceral adiposity is essential to assessing cardiometabolic risk, regardless of age, race, or BMI, and may serve as a marker and target of therapy in cardiometabolic disease.
- Published
- 2014